← FDA Drug Approvals (Drugs@FDA)
ETODOLAC
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA LTD · Approved 2026-07-15
Drug application
- FDA Application #
ANDA214872- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- ETODOLAC
- Generic name
- ETODOLAC
- Active ingredients
- ETODOLAC
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- AUROBINDO PHARMA LTD
- Manufacturer
- Aurobindo Pharma Limited
- First approval
- 2026-07-15
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown